Table 1.

Mean ± SD of all the measured parameters in brain homogenate of all treated groups compared with the control.

Parameters	Groups	N	Min.	Max.	Mean ± S.D.	Percent Change	p Value a	p Value b
MDA (µmoles/mL)	Control	10	0.31	0.35	0.330 ± 0.014	100.00		0.001
	PPA	10	0.45	0.47	0.460 ± 0.009	139.39	0.001
	FLX	10	0.35	0.37	0.360 ± 0.009	109.09	0.001
GSH (ug/mL)	Control	10	33.20	37.55	36.19 ± 1.66	100.00		0.001
	PPA	10	28.99	31.20	30.04 ± 0.83	83.00	0.001
	FLX	10	15.60	17.60	16.45 ± 0.86	45.45	0.001
Catalase (U/dl)	Control	10	5.25	7.50	6.23 ± 0.87	100.00		0.001
	PPA	10	4.20	5.30	4.67 ± 0.45	75.01	0.002
	FLX	10	3.89	5.20	4.59 ± 0.56	73.73	0.001
GST (U/mL)	Control	10	13.22	18.22	15.47 ± 1.71	100.00		0.001
	PPA	10	11.22	13.80	12.55 ± 0.97	81.11	0.002
	FLX	10	7.10	9.60	8.56 ± 0.84	55.33	0.001
K+ (mmol/L)	Control	10	5.10	6.33	5.60 ± 0.53	100.00		0.001
	PPA	10	4.31	5.22	4.82 ± 0.34	86.01	0.010
	FLX	10	2.50	3.44	2.94 ± 0.35	52.43	0.001
CK (IU/L)	Control	10	250.33	311.80	284.91 ± 22.10	100.00		0.001
	PPA	10	275.55	300.22	287.07 ± 10.38	100.76	0.954
	FLX	10	320.77	340.89	330.94 ± 7.17	116.16	0.001
IF γ (pg/100 mg)	Control	10	87.50	90.44	89.18 ± 1.15	100.00		0.001
	PPA	10	111.44	115.33	113.50 ± 1.42	127.27	0.001
	FLX	10	90.40	99.55	93.10 ± 3.28	104.39	0.013
Norepinephrine (ng/100 mg)	Control	10	4.55	5.50	5.05 ± 0.32	100.00		0.001
	PPA	10	3.09	3.88	3.46 ± 0.27	68.55	0.001
	FLX	10	3.99	5.11	4.82 ± 0.42	95.45	0.416
Serotonin (ng/100 mg)	Control	10	5.95	7.10	6.63 ± 0.39	100.00		0.001
	PPA	10	3.99	4.42	4.23 ± 0.14	63.87	0.001
	FLX	10	4.50	5.02	4.77 ± 0.18	72.03	0.001
Dopamine (ng/100 mg)	Control	10	20.97	22.50	21.88 ± 0.50	100.00		0.001
	PPA	10	14.59	16.00	15.08 ± 0.51	68.92	0.001
	FLX	10	15.17	17.09	16.08 ± 0.76	73.48	0.001
Caspase-3 (pg/100 mg)	Control	10	108.40	113.18	110.83 ± 1.76	100.00		0.001
	PPA	10	138.90	145.30	142.56 ± 2.40	128.62	0.001
	FLX	10	132.99	135.15	134.03 ± 0.93	120.93	0.001

^ap value between each group and the control group. ^b p value between all groups.